Michael Soulen on Chemoembolization for NET Liver Metastases

Article

Michael Soulen, MD, a professor of radiology and surgery at the Abramson Cancer Center, University of Pennsylvania, discusses chemoembolization to treat liver metastases in patients with neuroendocrine tumors (NETs).

Michael Soulen, MD, a professor of radiology and surgery at the Abramson Cancer Center, University of Pennsylvania, discusses chemoembolization to treat liver metastases in patients with neuroendocrine tumors (NETs).

Chemoembolization is used to treat NETs metastatic to the liver by administering highly concentrated chemotherapy drugs into the tumor and simultaneously blocking blood flow to the tumor with embolizing agents.

A new technique includes drug-eluding beads, which are soaked in a chemotherapy agent and cannot be broken down by the body. The beads are injected into the tumor and the drug is slowly released, allowing for a better drug retention over a longer period of time.

Related Videos
Meaghan Mooney, B.S.N., RN, OCN, during the Extraordinary Healer interview
Colleen O’Leary, DNP, RN, AOCNS, EBP-C, LSSYB, in an interview with Oncology Nursing News.
Michelle H. Johann, DNP, RN, PHN, CPAN, WTA, in an interview with Oncology Nursing News explaining surgical path cards
Alison Tray, of Hartford Healthcare, discusses her team's research on a multidisciplinary team approach to manage the cancer drug shortage
Related Content
© 2024 MJH Life Sciences

All rights reserved.